Page last updated: 2024-09-03

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Ischemia

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, L; Hu, L; Peng, G; Qiao, B; Tu, Q; Wang, Y; Xia, Z; Xiong, Y; Ye, Q1
al-Mehdi, AB; Dodia, C; Fisher, AB; Jain, MK1

Other Studies

2 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Ischemia

ArticleYear
Peroxiredoxin 6 attenuates ischemia‑ and hypoxia‑induced liver damage of brain‑dead donors.
    Molecular medicine reports, 2016, Volume: 13, Issue:1

    Topics: Blotting, Western; Brain Death; Cell Line; Cytoprotection; Glycerophosphates; Humans; Hypoxia; Intracellular Space; Ischemia; Liver; NF-kappa B; Peroxiredoxin VI; Phospholipase A2 Inhibitors; Phospholipases A2; Reactive Oxygen Species; Signal Transduction; Tissue Donors; Transfection

2016
A phospholipase A2 inhibitor decreases generation of thiobarbituric acid reactive substance during lung ischemia-reperfusion.
    Biochimica et biophysica acta, 1993, Mar-17, Volume: 1167, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Glycerophosphates; Ischemia; Lipid Peroxidation; Lung; Male; Organ Size; Perfusion; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances

1993